Linical Co

Linical Co Revenue per Share

The Revenue per Share of Linical Co (2183.T) as of Oct 24, 2026 is 383.67 JPY. In the previous year, Revenue per Share was 462.09 JPY — a change of -16.97% (lower).

Revenue per Share

383.67JPY

YoY

-16.97%

Last updated:

Revenue per Share of Linical Co is 2026 383.67 JPY. Revenue per Share of Linical Co was 2025 462.09 JPY. It decreases by -16.97% lower compared to the previous year.

The Linical Co Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2020
484.15 JPY
Jan 1, 2021
455.11 JPY
Jan 1, 2022
511.59 JPY
Jan 1, 2023
554.18 JPY
Jan 1, 2024
544.92 JPY
Jan 1, 2025
462.09 JPY
Jan 1, 2026
383.67 JPY
Jan 1, 2027 (e)
525.46 JPY
The Linical Co Revenue per Share history
YEARRevenue per ShareYoY
est525.46JPY+36.96%
383.67JPY-16.97%
462.09JPY-15.20%
544.92JPY-1.67%
554.18JPY+8.32%
511.59JPY+12.41%
455.11JPY-6.00%
484.15JPY-3.34%
500.89JPY+24.14%
403.48JPY+9.74%
367.68JPY+9.15%
336.86JPY+57.47%
213.92JPY+31.03%
163.26JPY+3.39%
157.90JPY+15.70%
136.47JPY+23.80%
110.24JPY-0.50%
110.80JPY+34.36%
82.46JPY+59.94%
51.56JPY+89.97%
27.14JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Revenue per Share of Linical Co is 383.67 JPY in 2026.

Revenue per Share of Linical Co changed from 462.09 JPY to 383.67 JPY, representing a -16.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Linical Co since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Linical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Linical Co